Vis enkel innførsel

dc.contributor.authorMori, Amani Thomasen_US
dc.contributor.authorKaale, Eliangiringa Amosen_US
dc.contributor.authorRisha, Peteren_US
dc.description.abstractBackground: Regulation of the pharmaceutical sector is a challenging task for most governments in the developing countries. In Tanzania, this task falls under the Food and Drugs Authority and the Pharmacy Council. In 2010, the Pharmacy Council spearheaded policy reforms in the pharmaceutical sector aimed at taking over the control of the regulation of the business of pharmacy from the Tanzania Food and Drugs Authority. This study provides a critical analysis of these reforms. Methods: The study employed a qualitative case-study design. Data was collected through in-depth interviews, focus group discussions and document reviews. Data was analyzed thematically using a policy triangle framework. The analysis was done manually. Results: The reforms adopted an incremental model of public policy-making and the process was characterized by lobbying for political support, negotiations and bargaining between the interest groups. These negotiations were largely centred on vested interests and not on the impact of the reforms on the efficiency of pharmaceutical regulations in the country. Stakeholders from the micro and meso levels were minimally involved in the policy reforms. Conclusion: Recent pharmaceutical regulation reforms in Tanzania were overshadowed by vested interests, displacing a critical analysis of optimal policy options that have the potential to increase efficiency in the regulation of the business of pharmacy. Politics influenced decision-making at different levels of the reform process.en_US
dc.publisherBioMed Centraleng
dc.rightsAttribution CC BYeng
dc.subjectPharmaceutical policyeng
dc.subjectPolicy reformseng
dc.subjectPolicy actorseng
dc.subjectPharmacy Acteng
dc.subjectPharmacy Councileng
dc.subjectTanzania Food and Drugs Authorityeng
dc.titleReforms: a quest for efficiency or an opportunity for vested interests'? a case study of pharmaceutical policy reforms in Tanzaniaen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderAmani Mori et al.; licensee BioMed Central Ltd.
dc.rights.holderCopyright 2013 Mori et al.; licensee BioMed Central Ltd.
dc.source.journalBMC Public Health

Tilhørende fil(er)


Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY